about
A genome-wide association study of carotid atherosclerosis in HIV-infected menVariants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrateTrans-ethnic Meta-analysis and Functional Annotation Illuminates theĀ Genetic Architecture of Fasting Glucose and Insulin.Genetic loci associated with circulating phospholipid trans fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium.Genomics of post-prandial lipidomic phenotypes in the Genetics of Lipid lowering Drugs and Diet Network (GOLDN) study.Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African Ancestry Anthropometry Genetics Consortium.Exome Genotyping Identifies Pleiotropic Variants Associated with Red Blood Cell Traits.APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.Association of Central Adiposity With Adverse Cardiac Mechanics: Findings From the Hypertension Genetic Epidemiology Network Study.Archeological Echocardiography: Digitization and Speckle Tracking Analysis of Archival Echocardiograms in the HyperGEN StudyA meta-analysis identifies new loci associated with body mass index in individuals of African ancestry.Genome-wide association of body fat distribution in African ancestry populations suggests new loci.Epigenetic Signatures of Cigarette Smoking.Visual Sensory and Visual-Cognitive Function and Rate of Crash and Near-Crash Involvement Among Older Drivers Using Naturalistic Driving Data.A data-driven method for identifying rare variants with heterogeneous trait effects.Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.Genome-wide detection of allele specific copy number variation associated with insulin resistance in African Americans from the HyperGEN study.Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: the Reasons for Geographic and Racial Differences in Stroke study.Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohortIncident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT studyPharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT StudyPharmacogenetic effects of 'candidate gene complexes' on stroke in the GenHAT study.Diastolic wall strain: a simple marker of abnormal cardiac mechanics.Epigenome-wide association study of fasting blood lipids in the Genetics of Lipid-lowering Drugs and Diet Network study.A systematic mapping approach of 16q12.2/FTO and BMI in more than 20,000 African Americans narrows in on the underlying functional variation: results from the Population Architecture using Genomics and Epidemiology (PAGE) study.Association of comorbidity burden with abnormal cardiac mechanics: findings from the HyperGEN studyApolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study.Genetic variants modify the effect of age on APOE methylation in the Genetics of Lipid Lowering Drugs and Diet Network study.PCSK9 variation and association with blood pressure in African Americans: preliminary findings from the HyperGEN and REGARDS studies.A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network.Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.Epigenome-wide study identifies novel methylation loci associated with body mass index and waist circumference.Epigenome-wide association study (EWAS) of BMI, BMI change and waist circumference in African American adults identifies multiple replicated lociRare PPARA variants and extreme response to fenofibrate in the Genetics of Lipid-Lowering Drugs and Diet Network Study.Association of DNA Methylation at CPT1A Locus with Metabolic Syndrome in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) StudyA family-specific linkage analysis of blood lipid response to fenofibrate in the Genetics of Lipid Lowering Drug and Diet NetworkHeritable DNA Methylation in CD4+ Cells among Complex Families Displays Genetic and Non-Genetic Effects.Association of Body Mass Index with DNA Methylation and Gene Expression in Blood Cells and Relations to Cardiometabolic Disease: A Mendelian Randomization Approach.Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension.
P50
Q24622468-F6EC7FE5-86B2-471C-9736-CAE2772269C4Q28484684-7B9BB301-6C64-44E8-AD82-BABAB5C1104DQ28596552-AD21FCA7-C6E3-4529-AAAD-5AECF3DCB794Q28651511-52EA8755-49E5-485F-A90A-A62F8E70DF97Q30009401-15846F28-3D16-44D7-BF75-C34676BA5A80Q30252516-1EEB7C86-876D-4EC2-9B68-945EFFA7372AQ30276497-1970B27C-1439-4DE0-A2F4-72EC9CE05FBCQ30279056-8A1FBA38-4ACF-48DA-8D81-A993694BDC7BQ30355036-47AEA018-57E4-460D-9C56-269116AAFE61Q30362171-277AD373-52C9-4FDC-A501-2362B522FBA9Q30416161-21343527-EA2F-429B-8198-96D00672E108Q30417624-8786714F-8B44-47EE-9A45-C73BCEE7A2DDQ30489866-0150FE2F-4711-40F3-82F6-BFACB77ACD95Q33792927-3B00A0EA-80F2-42F4-9B14-DD002AAFEEC8Q33983655-CD5245E2-5D6B-497F-B419-242FB38154FEQ33995658-DA232783-3E3E-4B1A-B11A-6A1C3E9DC569Q34013806-99BEB52A-EAE7-49D2-9D3E-99C36994972BQ34051223-6D39434E-8CD9-4F7D-B03D-D298B0D98023Q34078184-E7F0745F-B8C1-424D-8BB4-7F6F70C00A35Q34078187-32F967B0-1055-45FC-A557-EB0790C20089Q34193066-EE4EA7BD-6A3B-4000-992D-CEAF116223EAQ34212370-80092F49-8BBC-4C6F-8777-2ECF4260925BQ34307609-4933430B-F5D1-4CF4-8765-DA0321E91EF2Q34340475-E33BE569-C04E-4745-9C89-D53A7D3184AFQ34406002-DC7BF9F6-9C70-41A1-BA33-09AB30ECA64EQ34558031-70EAC8C0-D08A-4BF9-9056-47021A30A15BQ35021761-0360BD49-D19D-4D29-9A26-798EBA3EAB73Q35058300-EB11AC80-AC05-4D29-905D-D02A7219BB37Q35072904-9EB10BED-09CA-4CDD-92AA-5552BBAE36B5Q35315430-A57D7240-1EFB-4750-8A02-C8635C9B1EDAQ35745448-E0AB6ADF-5E7A-429E-B896-0A744124FEF5Q35763418-53B62072-C68E-4593-B714-C83B90D9486AQ35785914-9CBD0464-6468-409D-91CF-E62CB0F15148Q35821136-442E582A-E2C4-4C3F-BE25-91C15BCA1B7DQ35886146-C6B1942A-A89C-442F-BB90-A068A8BE2F9CQ35903795-0C2F3936-9536-4FA9-B8BD-79882CA9CB7FQ36021220-D0067E44-14A1-4DCD-9FB6-C52C1CCF0702Q36177302-3DF6D79F-6D23-4CF3-8FAE-96793FA1BCE3Q36251303-BDAB6F8E-DEDE-4FEF-A8C4-193CB3C9D295Q36299518-B5AB5EBB-A08F-4861-B967-47C076BD4677
P50
description
researcher
@en
wetenschapper
@nl
name
Marguerite R Irvin
@en
Marguerite R Irvin
@nl
type
label
Marguerite R Irvin
@en
Marguerite R Irvin
@nl
prefLabel
Marguerite R Irvin
@en
Marguerite R Irvin
@nl
P31
P496
0000-0002-1442-2023